Bausch + Lomb champions proactive eye health during Vision Health Month
TORONTO, May 1, 2017 /CNW/ - May is Vision Health Month in Canada. Bausch + Lomb, a leading global eye health company is solely dedicated to protecting and enhancing the gift of sight for millions of people around the world. Bausch + Lomb is using the month to inform Canadians about eye-disease prevention and vision health maintenance.
High on the list of eye health priorities this year, is the emergence of digital eye strain. Digital eye strain, also known as computer vision syndrome, is linked to exposure to high-energy visible or blue light from video screens. Although smartphones and tablets can complement a busy, active lifestyle, extensive use of digital devices can also challenge your vision.1
"While technology is empowering, it is also putting a large amount of stress on the human eye, especially for contact lens wearers," says Marc Botticella, Senior Product Manager, Bausch + Lomb Canada. "You blink up to 66% less when using a digital device, which can lead to dryness and eye discomfort2. At Bausch + Lomb, we are constantly honing our innovation edge. In fact, we've just added a product in market designed to address the issue of increased digital screen time."
Bausch + Lomb ULTRA® is the ideal contact lens for today's screen-centric world where digital devices are putting new demands on people's eyes. MoistureSeal® Technology helps to prevent lens dehydration that may be caused by reduced blink rates. To be sure this product is right for you, please always read and follow the label.
- 65% of people experience eye strain and discomfort after prolonged use of digital devices3
- 90% of people don't talk to their eye-care provider about their digital device use3
- People with perfect vision may experience symptoms such as blurred vision, eyestrain and headaches with improper computer use4
This Vision Health Month, Bausch + Lomb encourages Canadians to make eye health a priority and visit an Optometrist for a comprehensive eye exam.4
About Bausch + Lomb:
Bausch + Lomb, a Valeant Pharmaceuticals International, Inc. company, is a leading global eye health organization that is solely focused on protecting, enhancing, and restoring people's eyesight. Our core businesses include ophthalmic pharmaceuticals, contact lenses, lens care products, ophthalmic surgical devices and instruments. We develop, manufacture and market one of the most comprehensive product portfolios in our industry, which are available in more than 100 countries. www.bausch.ca.
1Contact Lens Spectrum, Volume: 31, Issue: Contact Lens Spectrum Special Edition 2016: Capturing Opportunity October 2016, page(s): 36-40
2Data on file. Bausch & Lomb Incorporated. Rochester, NY; 2013
3Digital Eye Strain. (2016, June 27). Retrieved April 18, 2017, from https://opticalprism.ca/digital-eye-strain-2/
4Digital Eye Strain. (2017, February 15). Retrieved April 13, 2017, from http://doctorsofoptometry.ca/computer- vision-syndrome-cvs/
SOURCE Bausch + Lomb
For further information: Media contacts: Omar Martinez, Senior Brand Manager, Bausch + Lomb, P: (905) 695-7644; Caroline De Silva, Director, Argyle Public Relationships, P: (416) 968-7311 ext. 231